Optimizing treatment in patients with early-stage HER2-positive breast cancer

Optimizing Treatment Outcomes in Lung & Breast Cancer - 08 MayПодробнее

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Optimizing adjuvant treatment in HR+/HER2- early breast cancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. VogelПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic TherapyПодробнее

WATCH NOW: Optimizing Early Breast Cancer Outcomes in the Community SettingПодробнее

Educational Sessions: "Optimizing the management of early stage TNBC"Подробнее

Optimizing the Management of Early-stage TNBC: Symptoms, Treatments, and RecurrenceПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. GradisharПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Alvaro Moreno-AspitiaПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. SolimanПодробнее

Sramila Aithal, MD | Neratinib and Dose Escalation | Optimizing Therapy for HER2+ DiseaseПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’ReganПодробнее

Optimizing Treatment for the Best Possible Outcomes: An Interview with Dr. Lisa CareyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. CareyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Kevin KalinskyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее